Rhythm Pharmaceuticals, Inc. RYTM Net margin
Net margin at other companies
Other financials
Where this comes from
Calculated from Rhythm Pharmaceuticals, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Rhythm Pharmaceuticals, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rhythm Pharmaceuticals, Inc.'s net margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rhythm Pharmaceuticals, Inc.'s net margin?
- Rhythm Pharmaceuticals, Inc. (RYTM) reported net margin of -93.3% in Q1 2026.
- How has Rhythm Pharmaceuticals, Inc.'s net margin changed year-over-year?
- Rhythm Pharmaceuticals, Inc.'s net margin increased by 24.3% year-over-year, from -123.3% to -93.3%.
- What is the long-term trend for Rhythm Pharmaceuticals, Inc.'s net margin?
- Over 4 years (2021 to 2025), Rhythm Pharmaceuticals, Inc.'s net margin has grown at a -53.5% compound annual growth rate (CAGR), from -2,207.1% to -103.6%.
- What does net margin mean?
- Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.